By examining short-term cultures (STCs) derived from paired BRAFV600E tumor biopsies collected prior to treatment (Pre) and upon onset of resistance to vemurafenib (Prog) from three melanoma patients38, we observed decreased levels of SIRT6 in two out of three samples upon resistance (Fig. 1f). The gene discussed is SIRT6; the disease is melanoma.